Search
Find a recruiting study
7,120 recruiting studies with US sites, from the official ClinicalTrials.gov registry (refreshed Oct 26, 2026). No sign-up needed.
Most recently updated studies · page 113 of 297
- Recruiting
A Clinical Study of GeminiOne TEER System for the Treatment of Severe, Symptomatic MR.
Sierra Valve LLC
- Location
- Thousand Oaks, CA
- Eligibility basics
- Ages 18+
- RecruitingPhase 4
Tirbanibulin for Pediatric Warts
The Skin Center Dermatology Group
- Location
- New City, NY
- Eligibility basics
- Ages 8–18
- RecruitingPhase 2
A Study of TAK-411 in Adults With Chronic Inflammatory Demyelinating Polyradiculoneuropathy (CIDP)
Takeda
- Location
- La Jolla, CA + 11 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 1
Achilles Tendinopathy Embolization
Joint & Vascular Institute
- Location
- Libertyville, IL
- Eligibility basics
- Ages 25–80
- RecruitingPhase 2
HP-211 Safety and Proof of Concept Dose Ranging Study in Patients With Type 2 Diabetes
Housey Healthcare ULC
- Location
- Canoga Park, CA + 24 other US sites
- Eligibility basics
- Ages 18+
- Recruiting
Cardiac RADIoablation Versus Repeat Catheter Ablation: a Pivotal Randomized Clinical Trial Evaluating Safety and Efficacy for Patients With High-risk Refractory Ventricular Tachycardia (RADIATE-VT)
Varian, a Siemens Healthineers Company
- Location
- Los Angeles, CA + 10 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2/Phase 3
Pharmacokinetics, Efficacy, and Safety of Encaleret in Pediatric Participants With Autosomal Dominant Hypocalcemia Type 1 (ADH1)
Calcilytix Therapeutics, Inc., a BridgeBio company
- Location
- New Haven, CT + 3 other US sites
- Eligibility basics
- Ages 0 mo–17
- RecruitingPhase 2
Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy
Supernus Pharmaceuticals, Inc.
- Location
- Jacksonville, FL + 1 other US site
- Eligibility basics
- Ages 18–70
- RecruitingPhase 4
Study Evaluating the Safety and Efficacy of Neffy or Intramuscular Adrenalin in Patients With Allergic Reactions After Oral Food Challenge or Allergen Immunotherapy
ARS Pharmaceuticals, Inc.
- Location
- La Jolla, CA + 5 other US sites
- Eligibility basics
- Ages 4+
- Recruiting
Gemini Study: A Prospective, Multicenter Evaluation of Performance and Safety of the Eversense Gemini System With Flash Glucose Measurement Feature
Senseonics, Inc.
- Location
- Escondido, CA
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Research Study on How Well Different Doses of the Medicine UBT251 Help People Living With Overweight or Obesity
Novo Nordisk A/S
- Location
- Cypress, CA + 1 other US site
- Eligibility basics
- Ages 18–65
- Recruiting
ROME GS System Study
Senseonics, Inc.
- Location
- Escondido, CA + 2 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
Merck Sharp & Dohme LLC
- Location
- Los Angeles, CA + 8 other US sites
- Eligibility basics
- Ages 1–17
- RecruitingPhase 2
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
GlaxoSmithKline
- Location
- Ann Arbor, MI + 4 other US sites
- Eligibility basics
- Ages 18+
- RecruitingPhase 3
Phase 3 Efficacy Study With Concurrent Control of IT MELPIDA in SPG50.Concurrent Controls.
Elpida Therapeutics SPC
- Location
- Dallas, TX
- Eligibility basics
- Ages 4 mo–6
- RecruitingPhase 3
A Study to Evaluate the Safety (Compared to Iron Sucrose), Efficacy and Pharmacokinetics of Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects With Chronic Kidney Disease (CKD)
AMAG Pharmaceuticals, Inc.
- Location
- Kansas City, MO + 3 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 3
A Study to Evaluate Ferumoxytol for the Treatment of Iron Deficiency Anemia (IDA) in Pediatric Subjects
AMAG Pharmaceuticals, Inc.
- Location
- Miami, FL + 2 other US sites
- Eligibility basics
- Ages 2–17
- RecruitingPhase 1/Phase 2
A Study of AAV9 Gene Therapy in Participants With Canavan Disease (CANaspire Clinical Trial)
Aspa Therapeutics
- Location
- Oakland, CA + 2 other US sites
- Eligibility basics
- Up to age 2
- RecruitingPhase 1/Phase 2
A Study to Investigate the Safety of DSP-3077 After a Unilateral Eye Injection in Male and Female Participants 18 Years of Age or Older With Retinitis Pigmentosa
Sumitomo Pharma America, Inc.
- Location
- Boston, MA + 1 other US site
- Eligibility basics
- Ages 18+
- Recruiting
PROMISE III: Percutaneous Deep Vein Arterialization for the Treatment of Late-Stage Chronic Limb-Threatening Ischemia
LimFlow, Inc.
- Location
- Gainesville, FL + 7 other US sites
- Eligibility basics
- Ages 18–95
- RecruitingPhase 1
A Phase 1, Dose Escalation Trial of RP-A601 in Subjects With PKP2 Variant-Mediated Arrhythmogenic Cardiomyopathy (PKP2-ACM)
Rocket Pharmaceuticals Inc.
- Location
- La Jolla, CA + 1 other US site
- Eligibility basics
- Ages 18+
- RecruitingPhase 2
A Long-term Extension Study of ORX750 in Participants With Narcolepsy and Idiopathic Hypersomnia
Centessa Pharmaceuticals (UK) Limited
- Location
- Auburn, AL + 18 other US sites
- Eligibility basics
- Ages 18–65
- Recruiting
Trial of Partial Enteral Nutrition With Dairy Free Diet in Eosinophilic Esophagitis
Kate Farms Inc
- Location
- Seattle, WA
- Eligibility basics
- Ages 1–21
- RecruitingPhase 3
Olpasiran Trials of Cardiovascular Events and Lipoprotein(a) Reduction - Coronary Computed Tomography Angiography Trial
Amgen
- Location
- Bridgeport, CT + 5 other US sites
- Eligibility basics
- Ages 35–80
Data source: deploy-time snapshot of the ClinicalTrials.gov API. How we list studies